Q2 2023 Biogaia AB Earnings Call Transcript
Welcome to BioGaia Q2 Conference Call for 2023. (Operator Instructions) Now I will hand the conference over to CEO, Isabelle Ducellier. Please go ahead.
()-&
Thank you, and good morning, everybody, for this interim management statement Q2 2023. So as an executive summary, just to point out the -- outline the main results in terms of sales we have SEK 315 million for the quarter 2. We can show a growth of 9%, 2% being organic and the rest currency effect driven by a strong growth in Americas, a slight decrease in Europe and relative growth in APAC, and I will come back to that later. Regarding the EBIT, it's a bit under the -- last year at minus 6% at SEK 95 million, but we maintained an EBIT margin of 30%.
Starting with the key events. I would like to emphasize on the third press release we published on the 5th of July informing the market about a very interesting clinical study. We've been running with Orebro University here in Sweden
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
